{
    "clinical_study": {
        "@rank": "16481", 
        "arm_group": {
            "arm_group_label": "Biomarkeres"
        }, 
        "brief_summary": {
            "textblock": "The primary aim of the present study is to investigate different biomarkers like VEGF, EVGF\n      and others ability to predict time to recidive and progressions free survival."
        }, 
        "brief_title": "Comparing of Different Biomarkers From Vena Rectalis Superior and Vena Cubiti in Patients Undergoing Low Anterior Resection for Rectum Cancer", 
        "completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Rectal Cancer", 
        "condition_browse": {
            "mesh_term": "Rectal Neoplasms"
        }, 
        "detailed_description": {
            "textblock": "Patients undergoing LAR for rectum cancer is subjected. Preoperative blood samples from vena\n      rectalis superior and vena cubiti is collected, as well as biopsies from tumor. Preoperative\n      and after 3 month peripheral blood samples is collected.\n\n      A total of 50 patients will be included in this study.\n\n      The study is approved by the local scientific ethical committee No. S-20100006"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Histological verified cancer\n\n          -  The cancer must be located in rectum maximum of 15 cm.\n\n          -  Age above 18\n\n        Exclusion Criteria:\n\n          -  Disseminated cancer\n\n          -  Perioperative radio-chemotherapy\n\n          -  Laparoscopy surgery"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Patients undergoing open LAR for rectum cancer is subjected."
            }
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 11, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01706809", 
            "org_study_id": "S-20100006", 
            "secondary_id": "S-20100006"
        }, 
        "intervention": {
            "arm_group_label": "Biomarkeres", 
            "intervention_name": "blood sampels from vena rectalis superior and vena cubiti", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "February 4, 2014", 
        "location": {
            "contact": {
                "email": "hans.rahr@slb.regionsyddanmark.dk", 
                "last_name": "Hans Rahr, MD", 
                "phone": "7940 5600", 
                "phone_ext": "0045"
            }, 
            "facility": {
                "address": {
                    "city": "Vejle", 
                    "country": "Denmark", 
                    "zip": "5000"
                }, 
                "name": "Vejle hospital"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Denmark"
        }, 
        "number_of_groups": "1", 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Denmark: Ethics Committee", 
                "Denmark: Danish Dataprotection Agency"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "The primary aim of the present study is to investigate different biomarkers like VEGF, EVGF and others ability to predict time to recidive and progressions free survival.", 
            "safety_issue": "No", 
            "time_frame": "after the study is complete"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01706809"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Odense University Hospital", 
            "investigator_full_name": "Mark Ellebaek Pedersen", 
            "investigator_title": "Medical doctor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Odense University Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Odense University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2011", 
        "study_design": "Observational Model: Case Control, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "February 2014"
    }
}